Recent Updates
Recently added Catalysts
ATHE Positive Sentiment Score: 85/100

Results of Extraordinary General Meeting MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA - 29 December 2023 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") advises that all resolutions considered

Key Takeaway: Alterity Therapeutics held an Extraordinary General Meeting on December 29, 2023, where all resolutions were approved by poll. The resolutions included ratification of prior share issues and approvals for new securities placements. A significant majority of votes were cast in favor, indicating considerable shareholder support for these decisions. Detailed voting results are also provided, highlighting the level of agreement among stakeholders.

Market Sentiment Analysis

POSITIVE FACTORS

  • All resolutions at the Extraordinary General Meeting were carried successfully.
  • High percentage of votes in favor reflects strong support from shareholders.
  • Resolutions include approvals for share placements which may enhance company capital.

Full Press Release Details

Results of Extraordinary General
MELBOURNE, AUSTRALIA AND SAN
FRANCISCO, USA - 29 December 2023 Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company")
advises that all resolutions considered at the Extraordinary General Meeting held today were carried by poll.
In accordance with ASX Listing rule 3.13.2
and Section 251AA(1) of the Corporations Act 2001, details of the proxies received and votes cast in respect of each resolution are attached.
Alterity Therapeutics Limited
Level 3, 62 Lygon Street Carlton
Victoria 3053 Australia
The following information is provided in accordance with
section 251AA(2) of the Corporations Act 2001 (Cth) and ASX Listing Rule 3.13.2.
Resolution details Instructions given to validly appointed proxies (as at proxy close) Number of votes cast on the poll (where applicable) Resolution Result
Resolution Resolution Type For Against Proxy's Discretion Abstain For Against Abstain* Carried / Not Carried
1 Ratification of prior issue of Shares Ordinary 150,828,432 81.93% 29,952,074 16.27% 3,312,470 1.80% 2,351,400 154,140,902 83.73% 29,952,074 16.27% 6,351,400 Carried
2 Approval for issue of Shares Ordinary 139,071,294 76.58% 39,235,586 21.60% 3,312,470 1.82% 4,845,426 142,383,764 78.40% 39,235,586 21.60% 8,845,426 Carried
3 Approval for issue of Options Ordinary 138,253,594 76.54% 39,033,686 21.61% 3,332,470 1.85% 5,644,626 141,586,064 78.39% 39,033,686 21.61% 9,644,626 Carried
4 Approval for issue of Securities - SPP Ordinary 135,532,712 73.88% 44,583,474 24.30% 3,332,470 1.82% 4,850,126 130,648,470 74.56% 44,583,474 25.44% 17,066,838 Carried
5A Approval of issue of Securities - Placement - Peter Marks Ordinary 136,391,908 73.89% 45,181,628 24.47% 3,024,662 1.64% 3,543,984 139,416,570 75.52% 45,181,628 24.48% 7,543,984 Carried
5B Approval of issue of Securities - Placement - Brian Meltzer Ordinary 135,291,600 73.16% 45,622,628 24.67% 4,016,970 2.17% 3,327,984 139,308,570 75.33% 45,622,628 24.67% 7,327,984 Carried
5C Approval of issue of Securities - Placement - Lawrence Gozlan Ordinary 136,345,000 73.71% 45,610,628 24.66% 3,016,970 1.63% 3,326,184 139,361,970 75.34% 45,610,628 24.66% 7,326,184 Carried
* Votes cast by a person who abstains on an item are not
counted in calculating the required majority on a poll.

Frequently Asked Questions

What was the outcome of the Extraordinary General Meeting?

All resolutions at the Extraordinary General Meeting were approved by poll.

How many votes were cast for the first resolution?

The first resolution received 154,140,902 votes in favor.

What percentage voted against the second resolution?

21.60% of the votes were against the second resolution.

What type of resolutions were voted on?

The resolutions were ordinary resolutions related to share issues.

How can I find more information about Alterity Therapeutics?

Visit their website at www.alteritytherapeutics.com for more information.

Last updated: Dec 29, 2023